Integra LifeSciences Stock Options
| IART Stock | USD 21.82 0.36 1.62% |
Integra LifeSciences' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.82 with a put-to-call open interest ratio of 0.5 over 21 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on June 20th 2025.
Open Interest Against June 20th 2025 Option Contracts
Integra LifeSciences option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Integra LifeSciences' lending market. For example, when Integra LifeSciences' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Integra LifeSciences, he or she must hedge the risk by shorting Integra LifeSciences stock over its option's life.
2025-06-20
The chart above shows Integra LifeSciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Integra LifeSciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Integra LifeSciences' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Integra LifeSciences
Analyzing Integra LifeSciences' in-the-money options over time can help investors to take a profitable long position in Integra LifeSciences regardless of its overall volatility. This is especially true when Integra LifeSciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Integra LifeSciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Integra LifeSciences' stock while costing only a fraction of its price.
Integra LifeSciences In The Money Call Balance
When Integra LifeSciences' strike price is surpassing the current stock price, the option contract against Integra LifeSciences Holdings stock is said to be in the money. When it comes to buying Integra LifeSciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Integra LifeSciences Holdings are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Integra Current Options Market Mood
Integra LifeSciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Integra Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Integra LifeSciences' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Integra LifeSciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Integra contract
Base on the Rule 16, the options market is currently suggesting that Integra LifeSciences Holdings will have an average daily up or down price movement of about 0.0513% per day over the life of the 2025-06-20 option contract. With Integra LifeSciences trading at USD 21.82, that is roughly USD 0.0112. If you think that the market is fully incorporating Integra LifeSciences' daily price movement you should consider buying Integra LifeSciences Holdings options at the current volatility level of 0.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Integra |
Purchasing Integra LifeSciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Integra calls. Remember, the seller must deliver Integra LifeSciences Holdings stock to the call owner when a call is exercised.
Integra LifeSciences Option Chain
When Integra LifeSciences' strike price is surpassing the current stock price, the option contract against Integra LifeSciences Holdings stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Integra LifeSciences' option chain is a display of a range of information that helps investors for ways to trade options on Integra. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Integra. It also shows strike prices and maturity days for a Integra LifeSciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IART250620C00040000 | 0 | 40.0 | 0.0 - 1.75 | 1.75 | |
Call | IART250620C00035000 | 13 | 35.0 | 0.0 - 1.75 | 0.55 | Out |
Call | IART250620C00030000 | 9 | 30.0 | 0.0 - 0.65 | 0.37 | Out |
Call | IART250620C00025000 | 72 | 25.0 | 0.0 - 3.3 | 2.55 | Out |
Call | IART250620C00022500 | 2 | 22.5 | 0.65 - 3.8 | 2.75 | Out |
Call | IART250620C00020000 | 1 | 20.0 | 1.65 - 5.4 | 5.5 | In |
Call | IART250620C00017500 | 1 | 17.5 | 3.5 - 7.3 | 5.7 | In |
Call | IART250620C00015000 | 1 | 15.0 | 5.9 - 9.5 | 9.01 | In |
Call | IART250620C00012500 | 0 | 12.5 | 9.1 - 12.0 | 9.1 | In |
Call | IART250620C00010000 | 0 | 10.0 | 10.3 - 14.4 | 10.3 | In |
Call | IART250620C00007500 | 2 | 7.5 | 13.6 - 16.8 | 16.0 | In |
Put | IART250620P00010000 | 0 | 10.0 | 0.0 - 1.75 | 1.75 | |
Put | IART250620P00012500 | 0 | 12.5 | 0.0 - 2.15 | 2.15 | |
Put | IART250620P00015000 | 4 | 15.0 | 0.0 - 2.25 | 0.47 | Out |
Put | IART250620P00017500 | 3 | 17.5 | 0.0 - 1.8 | 1.55 | Out |
Put | IART250620P00020000 | 12 | 20.0 | 0.0 - 2.4 | 1.7 | Out |
Put | IART250620P00022500 | 1 | 22.5 | 0.75 - 3.3 | 2.9 | In |
Put | IART250620P00025000 | 1 | 25.0 | 2.15 - 5.0 | 3.9 | In |
Put | IART250620P00030000 | 29 | 30.0 | 7.7 - 8.3 | 6.15 | In |
Put | IART250620P00035000 | 0 | 35.0 | 12.0 - 14.7 | 12.0 | In |
Put | IART250620P00040000 | 0 | 40.0 | 16.4 - 19.5 | 16.4 | In |
Integra Total Stockholder Equity
Total Stockholder Equity |
|
Integra LifeSciences Corporate Executives
Elected by the shareholders, the Integra LifeSciences' board of directors comprises two types of representatives: Integra LifeSciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Integra. The board's role is to monitor Integra LifeSciences' management team and ensure that shareholders' interests are well served. Integra LifeSciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Integra LifeSciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lea Knight | Executive CFO | Profile |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.